Delivery Order SPE2DB24D2003-SPE2DB26FXCR8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a contract ceiling value of $31,642.05. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract with a ceiling value of $16,930.73. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $81,786.40. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,313.76 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was awarded competitively and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Jardiance 25 mg tablets (90-count packaging) valued at $6,733.04 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by October 24, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $42,982.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Jardiance 25 mg tablets (90-count units). The contract, which is a non-set-aside competitive award, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 16, 2025. This delivery order represents a single transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract is valued at $1,807.80 and utilizes firm fixed price terms. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $11,024.17. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $18,509.94 under a firm fixed-price contract. This is a non-set-aside competitive award executed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,044.32 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 24, 2025. This delivery order, which is classified as a child contract under a larger indefinite delivery vehicle, is structured as a firm fixed price arrangement with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB26FXCR8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $23,033.06. This firm fixed-price delivery order, with an ultimate completion date of October 23, 2025, was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical distribution capabilities to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999.99 million through December 2026. As a critical vendor within the Defense Health Agency's supply chain, AmerisourceBergen utilizes this prime contract vehicle to deliver a broad spectrum of pharmaceutical products and medical supplies to military and veteran healthcare systems. The Jardiance order reflects the company's ongoing role in supplying prescription medications, including diabetes treatments, to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.0k | 10/22/25 |